Evaluation of Cyclic Peptide Inhibitors of the Grb7 Breast Cancer Target: Small Change in Cargo Results in Large Change in Cellular Activity

Grb7 is an adapter protein, overexpressed in HER2+ve breast and other cancers, and identified as a therapeutic target. Grb7 promotes both proliferative and migratory cellular pathways through interaction of its SH2 domain with upstream binding partners including HER2, SHC, and FAK. Here we present t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sang, Jianrong, Kulkarni, Ketav, Watson, Gabrielle M., Ma, Xiuquan, Craik, David J., Henriques, Sónia T., Poth, Aaron G., Benfield, Aurélie H., Wilce, Jacqueline A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832895/
https://www.ncbi.nlm.nih.gov/pubmed/31627265
http://dx.doi.org/10.3390/molecules24203739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832895/
https://www.ncbi.nlm.nih.gov/pubmed/31627265
http://dx.doi.org/10.3390/molecules24203739

Ejemplares similares